{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:28:07Z","timestamp":1754108887285,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1058522"],"award-info":[{"award-number":["APP1058522"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10620-019-05818-w","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:13:34Z","timestamp":1567790014000},"page":"1172-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-0361","authenticated-orcid":false,"given":"Yang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hanigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krupa","family":"Krishnaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reme E.","family":"Mountifield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Bampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Gearry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham L.","family":"Radford-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C.","family":"Lawrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"5818_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5694\/mja12.10654","volume":"197","author":"M Fransen","year":"2012","unstructured":"Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197:565\u2013568.","journal-title":"Med J Aust"},{"key":"5818_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","volume":"9","author":"V Annese","year":"2015","unstructured":"Annese V, Beaugerie L, Egan L, et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015;9:945\u2013965.","journal-title":"J Crohns Colitis"},{"key":"5818_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ijc.2910480504","volume":"48","author":"A Kricker","year":"1991","unstructured":"Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer\u2014a case\u2013control study. Int J Cancer. 1991;48:650\u2013662.","journal-title":"Int J Cancer"},{"key":"5818_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/BF01830242","volume":"5","author":"JL Bulliard","year":"1994","unstructured":"Bulliard JL, Cox B, Elwood JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control. 1994;5:234\u2013240.","journal-title":"Cancer Causes Control"},{"key":"5818_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/archderm.1995.01690140041006","volume":"131","author":"RP Gallagher","year":"1995","unstructured":"Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol. 1995;131:157\u2013163.","journal-title":"Arch Dermatol"},{"key":"5818_CR6","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/oxfordjournals.aje.a008875","volume":"144","author":"A Green","year":"1996","unstructured":"Nambour Study Group, Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol. 1996;144:1034\u20131040.","journal-title":"Am J Epidemiol"},{"key":"5818_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"AG Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30\u00a0year review. Gut. 2002;50:485\u2013489.","journal-title":"Gut"},{"key":"5818_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","volume":"2","author":"MC Dubinsky","year":"2004","unstructured":"Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004;2:731\u2013743.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5818_CR9","first-page":"CD000478","volume":"5","author":"A Timmer","year":"2016","unstructured":"Timmer A, Patton PH, Chande N, McDonald JW, MacDonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;5:CD000478.","journal-title":"Cochrane Database Syst Rev"},{"key":"5818_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomollon","year":"2017","unstructured":"Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325.","journal-title":"J Crohns Colitis"},{"key":"5818_CR11","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1126\/science.1114233","volume":"309","author":"P O\u2019Donovan","year":"2005","unstructured":"O\u2019Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871\u20131874.","journal-title":"Science"},{"key":"5818_CR12","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1056\/NEJMcibr054224","volume":"353","author":"JA Parrish","year":"2005","unstructured":"Parrish JA. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med. 2005;353:2712\u20132713.","journal-title":"N Engl J Med"},{"key":"5818_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0190-9622(00)90154-3","volume":"42","author":"P Jensen","year":"2000","unstructured":"Jensen P, Moller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 2000;42:307.","journal-title":"J Am Acad Dermatol"},{"key":"5818_CR14","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"S Euvrard","year":"2003","unstructured":"Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681\u20131691.","journal-title":"N Engl J Med"},{"key":"5818_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","volume":"9","author":"V Annese","year":"2015","unstructured":"Annese V, Beaugerie L, Egan L, et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohn\u2019s Colitis. 2015;9:945\u2013965.","journal-title":"J Crohn\u2019s Colitis"},{"key":"5818_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/ajg.2014.298","volume":"109","author":"AM Abbas","year":"2014","unstructured":"Abbas AM, Almukhtar RM, Loftus EV, Lichtenstein GR, Khan N. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014;109:1781\u20131793.","journal-title":"Am J Gastroenterol"},{"key":"5818_CR17","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/ajg.2009.745","volume":"105","author":"RG Armstrong","year":"2010","unstructured":"Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol. 2010;105:1604\u20131609.","journal-title":"Am J Gastroenterol"},{"key":"5818_CR18","doi-asserted-by":"crossref","first-page":"449e1","DOI":"10.1016\/j.cgh.2011.01.021","volume":"9","author":"FD Van Schaik","year":"2011","unstructured":"Van Schaik FD, van Oijen MG, HM Smeets, van der Heijden GJ, Siersema PD, Oldenburg B. Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased. Clin Gastroenterol Hepatol. 2011;9:449e1\u2013450e1. author reply 450\u2013451.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5818_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1440-1746.2011.06865.x","volume":"27","author":"M Setshedi","year":"2012","unstructured":"Setshedi M, Epstein D, Winter TA, Myer L, Watermeyer G, Hift R. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. J Gastroenterol Hepatol. 2012;27:385\u2013389.","journal-title":"J Gastroenterol Hepatol"},{"key":"5818_CR20","doi-asserted-by":"publisher","first-page":"1621\u201328e1\u20135","DOI":"10.1053\/j.gastro.2011.06.050","volume":"141","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141:1621\u201328e1\u20135.","journal-title":"Gastroenterology"},{"key":"5818_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ajg.2013.451","volume":"109","author":"J Ariyaratnam","year":"2014","unstructured":"Ariyaratnam J, Subramanian V. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2014;109:163\u2013169.","journal-title":"Am J Gastroenterol"},{"key":"5818_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1158\/1055-9965.EPI-14-1203","volume":"24","author":"AE Cust","year":"2015","unstructured":"Cust AE, Pickles KM, Goumas C, et al. Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults. Cancer Epidemiol Biomark Prev. 2015;24:736\u2013743.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5818_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0733-8635(18)30809-X","volume":"4","author":"AN Lin","year":"1986","unstructured":"Lin AN, Carter DM. Skin cancer in the elderly. Dermatol Clin. 1986;4:467\u2013471.","journal-title":"Dermatol Clin"},{"key":"5818_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0190-9622(88)70270-4","volume":"19","author":"A Green","year":"1988","unstructured":"Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D. Skin cancer in a Queensland population. J Am Acad Dermatol. 1988;19:1045\u20131052.","journal-title":"J Am Acad Dermatol"},{"key":"5818_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/bmj.299.6708.1118","volume":"299","author":"I Harvey","year":"1989","unstructured":"Harvey I, Lear JT, Szeimies RM. Non-melanoma skin cancer. BMJ. 1989;299:1118\u20131120.","journal-title":"BMJ"},{"key":"5818_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","volume":"8","author":"MD Long","year":"2010","unstructured":"Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268\u2013274.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5818_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cgh.2012.10.038","volume":"11","author":"M Camus","year":"2013","unstructured":"Camus M, Seksik P, Bourrier A, et al. Long-term outcome of patients with Crohn\u2019s disease who respond to azathioprine. Clin Gastroenterol Hepatol. 2013;11:389\u2013394.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5818_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","volume":"141","author":"H Singh","year":"2011","unstructured":"Singh H, Nugent Z, Demers AA, et al. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. Gastroenterology. 2011;141:1612\u20131620.","journal-title":"Gastroenterology"},{"key":"5818_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/aje\/153.10.1021","volume":"153","author":"M Cockburn","year":"2001","unstructured":"Cockburn M, Hamilton A, Mack T. Recall bias in self-reported melanoma risk factors. Am J Epidemiol. 2001;153:1021\u20131026.","journal-title":"Am J Epidemiol"},{"key":"5818_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/aje\/kwn363","volume":"169","author":"CL Parr","year":"2009","unstructured":"Parr CL, Hjart\u00e5ker A, Laake P, Lund E, Veier\u00f8d MB. Recall bias in melanoma risk factors and measurement error effects: a nested case-control study within the Norwegian Women and Cancer Study. Am J Epidemiol. 2009;169:257\u2013266.","journal-title":"Am J Epidemiol"},{"key":"5818_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jclinepi.2012.06.014","volume":"65","author":"CJ Morze","year":"2012","unstructured":"Morze CJ, Olsen CM, Perry SL, et al. Good test-retest reproducibility for an instrument to capture self-reported melanoma risk factors. J Clin Epidemiol. 2012;65:1329\u20131336.","journal-title":"J Clin Epidemiol"},{"key":"5818_CR32","unstructured":"Australian Institute of Health and Welfare. 2016. Skin cancer in Australia. Cat. no. CAN 96. Canberra: AIHW."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05818-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:26:21Z","timestamp":1599261981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05818-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5818"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05818-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}